We are also in consulting of new drugs, product line planning, IPO feasibility study report, acquisition evaluation, professional comb and assessment of enterprises information.
*We have established a unique database, keeping track of domestic and foreign progress of research and authority review of new drugs, kind of pioneer here in China.
*Customized and professional consultation services ~ for portfolio planning with strategic screening of new drugs and new products ~ for evaluation of market situation, production technology, clinical feasibility ~ for merger evaluation and for marketing contrive of new products:
1、Professional Project Research;
2、Pipeline Planning- Strategic Product development;
3、Mergers project evaluation and analysis;
4、Market potential analysis of new products;
5、Other Medical special research.
Our Completed Consulting Project：
Strategic Planning the Intravenous infusion Pipeline for Baxter (China) International Inc.
Evaluation and analysis of a Chinese traditional Medicine project for Tianjin Smith Kline & French laboratories Ltd.
Chinese Marketing Evaluation of technology Tumor nano-microemulsion for Bridgetech Asia Limited，a American Company
Re-registration Service for Bachmann Medical Device Project from Germany
Registration Project of Medical Device of Diagnostic Reagent for Taiwanese company TaiXiang
Chinese market admission Feasibility Analysis of a new oral formulation, as a medical device, for Meiko Corporation , a Japanese Company
Strategic Planning of pipeline and evaluation of a second class new drug for Jingxin Pharm，a Zhejiang Province Listed company
Strategic Planning of R &D pipeline for JFK Pharm Ltd. ， a Hebei Province Listed company
Construction Planning of the drug institution for PKUCARE pharmacuetical R&D Center
Marketing Evaluation of a first class new dipine drug for China Pharmaceutical University
Feasibility Analysis of a first class new drug for Beijing Kawin Technology Share-Holding Co., Ltd.
Strategic Planning of R &D pipeline for Guangzhou Baiyunshan zhongyi pharm Co., Ltd., a Guangdong Province Listed company
Long-term cooperation with Zhuhai Commonwealth Pharmaceutical, Shijiazhuang Pharmaceutical Group, Taiji Group, Chengdu Guoguang Pharmaceutical, Zhejiang Wellcome Pharmaceutical, Hainan Changan, Hainan Huanglong, Beijing Kangyuan, Tetra Pak Branch, Shenzhen Ruilin, Beijing Honghui, South Korea and the United States medicine industry
